Paxvax, Inc.
2Patents
2Active
2Granted
43Portfolio score
Filing activity: Jul 30, 2010 → Nov 3, 2011
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8865182B2 | Adenoviral-based vectors | Emerging Cross-Sectional Technologies | 10 | Active |
| US9408899B2 | Vaccines against Toxoplasma gondii | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.